Skip to main content
Robert Chin, MD, Radiation Oncology, Los Angeles, CA

RobertKaidaChinMD

Radiation Oncology Los Angeles, CA

Assistant Professor of Radiation and Cellular Oncology, University of Chicago Medicine

Dr. Chin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chin's full profile

Already have an account?

  • Office

    200 Medical Plz
    Suite B265
    Los Angeles, CA 90095
    Phone+1 310-301-9775
    Fax+1 310-794-9795

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 2007 - 2011
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 2006 - 2007
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2006

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2014 - Present
  • CA State Medical License
    CA State Medical License 2007 - 2025
  • WA State Medical License
    WA State Medical License 2012 - 2017
  • IL State Medical License
    IL State Medical License 2006 - 2014
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2013

Publications & Presentations

PubMed

Press Mentions

  • Testimonial: Tongue Cancer TORS Surgery
    Testimonial: Tongue Cancer TORS SurgeryNovember 8th, 2024
  • Identifying Unique Genetic Variants to Overcome Cancer Treatment Barriers
    Identifying Unique Genetic Variants to Overcome Cancer Treatment BarriersNovember 4th, 2021